{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:39:18Z","timestamp":1771562358833,"version":"3.50.1"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100019004","name":"deanship of Scientific Research at Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["94\/2019"],"award-info":[{"award-number":["94\/2019"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019004","name":"deanship of Scientific Research at Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["128\/2020"],"award-info":[{"award-number":["128\/2020"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010272","name":"Deanship of Scientific Research at Zarqa University","doi-asserted-by":"publisher","award":["12\/2015"],"award-info":[{"award-number":["12\/2015"]}],"id":[{"id":"10.13039\/501100010272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Glyoxalase-I (Glo-I) enzyme is recognized as an indispensable druggable target in cancer treatment. Its inhibition will lead to the accumulation of toxic aldehyde metabolites and cell death. Paramount efforts were spent to discover potential competitive inhibitors to eradicate cancer.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Based on our previously work on this target for discovering potent inhibitors of this enzyme, herein, we address the discovery of the most potent Glo-I inhibitors reported in literature with two digits nano-molar activity. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Molecular docking and in vitro assay were performed to discover these inhibitors and explore the active site's binding pattern. A detailed SAR scheme was generated, which identifies the significant functionalities responsible for the observed activity.  <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Compound 1 with an IC50 of 16.5 nM exhibited the highest activity, catechol moiety as an essential zinc chelating functionality. It has been shown by using molecular modeling techniques that the catechol moiety is responsible for the chelation zinc atom at the active site, an essential feature for enzyme inhibition.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Catechol derivatives are successful zinc chelators in the Glo-I enzyme while showing exceptional activity against the enzyme to the nanomolar level.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406417666210714170403","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T14:15:54Z","timestamp":1626358554000},"page":"473-483","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of the First \u201cTwo Digit Nano-molar\u201d Inhibitors of the Human Glyoxalase-I Enzyme as Potential Anticancer Agents"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-900X","authenticated-orcid":true,"given":"Qosay A.","family":"Al\u2011Balas","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and\nTechnology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Al-Sha'er","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Zarqa University, Zarqa, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and\nTechnology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra\u2019a","family":"Al Zou\u2019bi","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and\nTechnology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"Siegel R.","year":"2014","unstructured":"Siegel R.; Ma J.; Zou Z.; Jemal A.; Cancer statistics, 2014. CA Cancer J Clin 2014,64(1),9-29","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1158\/0008-5472.CAN-06-4626","volume":"67","author":"Prendergast G.C.","year":"2007","unstructured":"Prendergast G.C.; Jaffee E.M.; Cancer immunologists and cancer biologists: why we didn\u2019t talk then but need to now. Cancer Res 2007,67(8),3500-3504","journal-title":"Cancer Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0006-291X(69)90445-8","volume":"35","author":"Vince R.","year":"1969","unstructured":"Vince R.; Wadd W.B.; Glyoxalase inhibitors as potential anticancer agents. Biochem Biophys Res Commun 1969,35(5),593-598","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/jm00283a009","volume":"14","author":"Vince R.","year":"1971","unstructured":"Vince R.; Daluge S.; Glyoxalase inhibitors. A possible approach to anticancer agents. J Med Chem 1971,14(1),35-37","journal-title":"J Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1159\/000367800","volume":"37","author":"Geng X.","year":"2014","unstructured":"Geng X.; Ma J.; Zhang F.; Xu C.; Glyoxalase I in tumor cell proliferation and survival and as a potential target for anticancer therapy. Oncol Res Treat 2014,37(10),570-574","journal-title":"Oncol Res Treat"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0021-9258(18)56017-8","volume":"190","author":"Racker E.","year":"1951","unstructured":"Racker E.; The mechanism of action of glyoxalase. J Biol Chem 1951,190(2),685-696","journal-title":"J Biol Chem"},{"key":"ref=7","author":"Chasseaud L.","year":"1983","unstructured":"Chasseaud L.;  Functions of glutathione: Biochemical, physiological, toxicological and clinical aspects 1983","journal-title":"Functions of glutathione: Biochemical, physiological, toxicological and clinical aspects"},{"key":"ref=8","first-page":"763","volume":"14","author":"Carrington S.","year":"1986","unstructured":"Carrington S.; The glyoxalase enigma. The biological consequences of a ubiquitous enzyme. IRCS Med Sci 1986,14,763-768","journal-title":"IRCS Med Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1010632919129","volume":"66","author":"Rulli A.","year":"2001","unstructured":"Rulli A.; Carli L.; Romani R.; Baroni T.; Giovannini E.; Rosi G.; Talesa V.; Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat 2001,66(1),67-72","journal-title":"Breast Cancer Res Treat"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00130404-200605000-00011","volume":"12","author":"Antognelli C.","year":"2006","unstructured":"Antognelli C.; Baldracchini F.; Talesa V.N.; Costantini E.; Zucchi A.; Mearini E.; Overexpression of glyoxalase system enzymes in human kidney tumor. Cancer J 2006,12(3),222-228","journal-title":"Cancer J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/S0959-8049(02)00236-8","volume":"38","author":"Mearini E.","year":"2002","unstructured":"Mearini E.; Romani R.; Mearini L.; Antognelli C.; Zucchi A.; Baroni T.; Porena M.; Talesa V.N.; Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas. Eur J Cancer 2002,38(14),1946-1950","journal-title":"Eur J Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood.V95.10.3214","volume":"95","author":"Sakamoto H.","year":"2000","unstructured":"Sakamoto H.; Mashima T.; Kizaki A.; Dan S.; Hashimoto Y.; Naito M.; Tsuruo T.; Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 2000,95(10),3214-3218","journal-title":"Blood"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/0006-2952(92)90680-H","volume":"44","author":"Lo T.W.","year":"1992","unstructured":"Lo T.W.; Thornalley P.J.; Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro. Biochem Pharmacol 1992,44(12),2357-2363","journal-title":"Biochem Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.3390\/molecules171213740","volume":"17","author":"Al-Balas Q.","year":"2012","unstructured":"Al-Balas Q.; Hassan M.; Al-Oudat B.; Alzoubi H.; Mhaidat N.; Almaaytah A.; Generation of the first structure-based pharmacophore model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors. Molecules 2012,17(12),13740-13758","journal-title":"Molecules"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1389557518666181009141231","volume":"19","author":"Al-Balas Q.A.","year":"2019","unstructured":"Al-Balas Q.A.; Hassan M.A.; Al-Shar\u2019i N.A.; Al Jabal G.A.; Almaaytah A.M.; Al-Shar\u2019I, N.A.; Al Jabal, G.A.; Almaaytah, A.M. Recent advances in glyoxalase-I inhibition. Mini Rev Med Chem 2019,19(4),281-291","journal-title":"Mini Rev Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110663","volume":"131","author":"He Y.","year":"2020","unstructured":"He Y.; Zhou C.; Huang M.; Tang C.; Liu X.; Yue Y.; Diao Q.; Zheng Z.; Liu D.; Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. Biomed Pharmacother 2020,131","journal-title":"Biomed Pharmacother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1248\/bpb.b15-00710","volume":"39","author":"Takasawa R.","year":"2016","unstructured":"Takasawa R.; Shimada N.; Uchiro H.; Takahashi S.; Yoshimori A.; Tanuma S.; TLSC702, a novel inhibitor of human glyoxalase I, induces apoptosis in tumor cells. Biol Pharm Bull 2016,39(5),869-873","journal-title":"Biol Pharm Bull"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/DDDT.S110997","volume":"10","author":"Al-Balas Q.A.","year":"2016","unstructured":"Al-Balas Q.A.; Hassan M.A.; Al-Shar\u2019i N.A.; Mhaidat N.M.; Almaaytah A.M.; Al-Mahasneh F.M.; Isawi I.H.; Novel glyoxalase-I inhibitors possessing a \u201czinc-binding feature\u201d as potential anticancer agents. Drug Des Devel Ther 2016,10,2623-2629","journal-title":"Drug Des Devel Ther"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.compbiolchem.2019.03.011","volume":"80","author":"Al-Sha\u2019er M.A.","year":"2019","unstructured":"Al-Sha\u2019er M.A.; Al-Balas Q.A.; Hassan M.A.; Al Jabal G.A.; Almaaytah A.M.; Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents. Comput Biol Chem 2019,80,102-110","journal-title":"Comput Biol Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00044-019-02486-3","volume":"29","author":"Al-Shari N.A.","year":"2019","unstructured":"Al-Shari N.A.; Al-Rousan E.K.; Fakhouri L.I.; Al-Balas Q.A.; Hassan M.A.; Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking. Med Chem Res 2019,29(3),356-376","journal-title":"Med Chem Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2174\/1570180814666170306120954","volume":"14","author":"Al-Balasa A.Q.","year":"2017","unstructured":"Al-Balasa A.Q.; Hassana A.M.; Al Jabala A.G.; Novel thiazole carboxylic acid derivatives possessing a \u201czinc binding feature\u201d as potential human glyoxalase-i inhibitors. Lett Drug Des Discov 2017,14(11),1324-1334","journal-title":"Lett Drug Des Discov"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"115608","DOI":"10.1016\/j.bmc.2020.115608","volume":"28","author":"Al-Oudat B.A.","year":"2020","unstructured":"Al-Oudat B.A.; Jaradat H.M.; Al-Balas Q.A.; Al-Shar\u2019i N.A.; Bryant-Friedrich A.; Bedi M.F.; Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents. Bioorg Med Chem 2020,28(16),115608-115625","journal-title":"Bioorg Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2174\/1573409916666200117100326","volume":"16","author":"Al-Sha\u2019er M.A.","year":"2020","unstructured":"Al-Sha\u2019er M.A.; Al-Balas Q.A.; Hassan M.A.; Combined high throughput screening with QSAR analysis unravelling potential glyoxalase-I inhibitors. Curr. Comput. Aided. Drug Des 2020,16(6),814-832","journal-title":"Drug Des"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2478\/acph-2021-0005","volume":"71","author":"Al-Shar\u2019i N.A.","year":"2021","unstructured":"Al-Shar\u2019i N.A.; Al-Balas Q.A.; Hassan M.A.; El-Elimat T.M.; Aljabal G.A.; Almaaytah A.M.; Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold. Acta Pharm 2021,71(1),115-130","journal-title":"Acta Pharm"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ddr.21421","volume":"79","author":"Al-Balas Q.A.","year":"2018","unstructured":"Al-Balas Q.A.; Hassan M.A.; Al-Shar\u2019i N.A.; El-Elimat T.; Almaaytah A.M.; Computational and experimental exploration of the structure-activity relationships of flavonoids as potent glyoxalase-I inhibitors. Drug Dev Res 2018,79(2),58-69","journal-title":"Drug Dev Res"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406417666210714170403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194791\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406417666210714170403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T06:47:53Z","timestamp":1666939673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194791\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406417666210714170403","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}